Smartwatches have added incredibly sophisticated health features in recent years, with the ability to take electrocardiograms to diagnose atrial fibrillation and monitor your blood oxygen levels. But if rumors are to be believed, Samsung’s next iteration of the Galaxy Watch and Apple Watch Series 7 may attempt a holy grave of health tools: Non-invasive blood sugar monitoring.
Report comes from ETNews, Which claims that Samsung plans to launch the feature in the second half of this year with the so-called Galaxy Watch 4, or possibly the Galaxy Watch Active 3. 7 series and required patent is “safe”. In both cases, glucose-Monitoring will be done through non-invasive optical sensors.
This is a classic case of “true then big”. That said, it is not out of the realm of possibility. In 2020, Samsung did Work closely with MIT To develop a non-invasive method for blood sugar-Use monitoring Raman spectroscopy And presented its findings in Science advance. Such as Apple, blood glucose-Surveillance rumors floated Everywhere For some time. Back in 2017, CNBC Reported The company had a “secret group” of biomedical engineers working on a project to develop non-invasive sensors that could monitor blood sugar levels. The initiative was initiated by Steve Jobs, and at the time, progressed to clinical trials in the Bay Area. according to this MacRumors, During that time Apple CEO Tim Cook was also spotted Wearing a potential prototype The glucose monitor is connected to their Apple Watch.
At CES 2021, a wearer was also standing outside – you guessed it Non-invasive blood glucose-Smartwatch monitoring From the Japanese startup Quantum Operation. This prototype was capable of measuring blood sugar in real-time through the wrist, and also used “patented spectrum sensing technology”.
So while it is likely that we can see non-invasive glucose-It is also a good idea to monitor somewhere down the line, a little skeptical about timing. This technique will obviously be a boon for diabetics, who have to prick their skin several times a day for blood sugar readings. It will be a game-changer – but only if it is Exceptionally accurate, with low margin of error, and approved by regulatory bodies suitable for consumer use. The ETNews report claimed that Apple is “focused on gaining reliability and stability before commercializing this technology”, but this particular phase can last anywhere from several months to several years.
The FDA must sign any blood sugar-monitoring smartwatch facility, which can be a lengthy process. IETNews reports, Wayne Not 100% true, not being told whether FDA approval would be safeguarded by Samsung or Apple in late summer or fall, when companies have historically released new smartwatches. And, if the technology never reaches a reliable degree of accuracy, it is likely that it never makes its way to the wrist.
Right now, it’s too early to call on blood sugar-Surveillance will make an appearance on both next-gen Samsung and Apple smartwatches. After all, no one was expecting an FDA-cleared ECG with the Series 4, but what if the company managed to shut it down in 2021? This will be the biggest update to any smartwatch we’ve seen so far.